Related Experiment Video

Updated: May 13, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in

Z M Younossi1, L Zheng, M Stepanova

  • 1Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA 22042, USA. zobair.younossi@inova.org

Alimentary Pharmacology & Therapeutics
|February 26, 2013
PubMed

Insights

For patients with chronic hepatitis C (CH-C), moderate alcohol consumption significantly increases the risk of overall and liver-related mortality. This study highlights the detrimental effects of alcohol on CH-C patient outcomes.

Area of Science:

  • Hepatology
  • Public Health
  • Epidemiology

Background:

  • The long-term effects of moderate alcohol intake in chronic hepatitis C (CH-C) patients are debated.
  • Understanding these effects is crucial for patient management and public health strategies.

Purpose of the Study:

  • To investigate the impact of moderate alcohol consumption on long-term mortality in CH-C patients.
  • Utilizing population-based data to provide robust evidence on this association.

Main Methods:

  • Analysis of the NHANES III-mortality linked files.
  • Quantification of alcohol consumption in grams per day.
  • Application of multivariate Cox proportional hazards models to assess mortality risks.

Main Results:

  • CH-C patients exhibited elevated risks for both overall and liver-related mortality.
  • Moderate (1-19 g/day) and heavy (≥30 g/day) alcohol consumption amplified these mortality risks in CH-C patients.
  • Increased overall mortality risk was observed with moderate and heavy alcohol consumption in CH-C patients.

Conclusions:

  • Chronic hepatitis C independently increases mortality risks.
  • Alcohol consumption, even at moderate levels, exacerbates mortality risks in CH-C patients.
  • Avoiding alcohol is critical for improving long-term outcomes in individuals with CH-C.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...